HealthEquity raises fiscal 2027 guidance after Q2 results

HealthEquity (NASDAQ: HQY ) reported second-quarter financial results on Thursday.

The transcript from the company's second-quarter earnings call has been provided below.

This transcript is brought to you APIs.

For real-time access to our entire catalog, please visit for a consultation.

The full earnings call is available at Summary HealthEquity delivered strong Q2 fiscal 2027 results with accelerated revenue growth of 8% year over year and a record adjusted EBITDA margin of 48%.

HSA accounts reached a record 10.7 million, with total HSA assets up 14% year over year.

Strategic initiatives included the launch of the Investor Answers tool and plans for a next-generation app to enhance member engagement.

The company reported a record $65.6 million GAAP net income and raised its fiscal 2027 guidance.

Management emphasized the importance of healthcare affordability and the role of HSAs in addressing this challenge, with strong client retention and a focus on technology and AI for operational efficiency.

Full Transcript Rocco, Operator Good day and welcome to the HealthEquity second quarter 2027 earnings conference call.

All participants will be in listen-only mode.

Should you need assistance, please signal for a specialist by pressing the star key followed by zero.

Please note that today's event is being recorded.

I'd now like to turn the conference over to Richard Putnam with Investor Relations.

Please go ahead, sir.

Richard Putnam, Investor Relations Thank you, Rocco.

Good morning, everyone.

Thank you for joining us for HealthEquity second quarter fiscal 2027 earnings conference call.

As Rocco said, my name is Richard Putnam.

I do Investor Relations for HealthEquity.

Joining me today are Scott Cutler, President and CEO, Dr.

Steve Neeleman, Vice Chair and Founder of the company, and James Lucania, Executive Vice President and CFO.

A press release announcing our second quarter financial results was issued earlier this morning and includes certain non-GAAP financial measures that we will reference.

You can find a copy of today's press release, including reconciliations of these non-GAAP measures with comparable GAAP measures, on our Investor Relations website, which is ir.healthequity.com.

Our comments and responses to your questions reflect management's view as of today, August 27, 2026, and will contain forward-looking statements as defined by the SEC, including predictions, expectations, estimates, or other information that might be considered forward-looking.

There are many important factors relating to our business which could affect our results.

These forward-looking statements are subject to risks and uncertainties that may cause our actual results to differ materially from statements made here today.

We caution against placing undue reliance on these forward-looking statements, and we also encourage you to review the discussion of these factors and other risks that may affect our future results or the market price of our stock as detailed in our latest Annual Report on Form 10-K and subsequent periodic reports filed with the SEC.

We assume no obligation to revise or update these forward-looking statements in light of new information or future results.

Before I turn this call over to Scott, I want to cover three brief updates.

First, we recently launched Investor Answers, an AI-enabled tool on our Investor Relations website that makes HealthEquity's disclosed materials easier to search and navigate.

You can find this on the menu of our Investor Relations landing page, and we welcome your feedback as we continue to improve the experience.

Second, as a reminder of the cadence we set last year, we expect to publish year-end sales metrics after the conclusion of our January 31st fiscal year, and we will provide fiscal 2028 guidance when we report our fiscal 2027 year-end financial results.

And finally, we're excited to welcome you to our Draper headquarters for our next Investor Day.

It's scheduled for April 13, 2027.

Please save the date, and we will share additional information and details as we get closer.